iHuman (IH) Stock Price, News & Analysis

Company Overview

iHuman Inc. is a leading provider of online education services in China, focused on delivering interactive and engaging learning experiences for preschool and primary school students. Through its flagship platforms, iHuman offers a wide range of digital content spanning language arts, mathematics, science and social studies. The company’s curriculum is designed to align with national educational standards while incorporating game-based learning and multimedia elements to maintain student interest and foster foundational skills.

At the core of iHuman’s offerings are its mobile and web applications, which feature animated lessons, phonics training, storybooks and assessment tools. Leveraging cloud-based infrastructure, the company enables real-time progress tracking and performance analytics for parents and educators. In addition to its core reading and literacy programs, iHuman has expanded into STEM subjects and creative arts, providing a holistic suite of products that address various stages of early childhood development.

Technology underpins iHuman’s instructional model, with adaptive learning algorithms tailoring content to each student’s proficiency level and learning pace. The company has invested heavily in artificial intelligence and natural language processing to enhance speech recognition, pronunciation correction and personalized feedback. These innovations aim to replicate one-on-one tutoring experiences at scale, ensuring that learners receive targeted support in areas where they face challenges.

Founded in Shanghai in 2010 by educational entrepreneur Zhang Wenjie, iHuman has grown to serve millions of users across mainland China. The leadership team combines expertise in pedagogy, software engineering and digital media, positioning the company at the intersection of education and technology. Under the board chairmanship of Liu Ying and the ongoing guidance of its founding CEO, iHuman continues to pursue strategic partnerships with schools, publishers and technology firms to extend its reach and enhance its content library.

Key Stats

• Today's Range: $2.45 to $2.46
• 50-Day Range: $2.08 to $2.60
• 52-Week Range: $1.47 to $3.18
• Volume: 2,951 shs
• Average Volume: 39,239 shs
• Market Capitalization: $127.97 million
• P/E Ratio: 9.11
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iHuman Stock Analysis - MarketRank™

iHuman scored higher than 31% of companies evaluated by MarketBeat, and ranked 221st out of 286 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iHuman.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iHuman is 9.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.86.

Price to Earnings Ratio vs. Sector

The P/E ratio of iHuman is 9.00, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 20.80.

Price to Book Value per Share Ratio

iHuman has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.08% of the float of iHuman has been sold short.

Short Interest Ratio / Days to Cover

iHuman has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iHuman has recently increased by 32.76%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iHuman does not currently pay a dividend.

Dividend Growth

iHuman does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.08% of the float of iHuman has been sold short.

Short Interest Ratio / Days to Cover

iHuman has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iHuman has recently increased by 32.76%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: N/A

News Sentiment

iHuman has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Consumer Discretionary companies.

MarketBeat Follows

1 people have added iHuman to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iHuman insiders have not sold or bought any company stock.

Percentage Held by Insiders

63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 4.92% of the stock of iHuman is held by institutions.

IH Stock Analysis - Frequently Asked Questions

How have IH shares performed this year?

iHuman's stock was trading at $1.69 on January 1st, 2025. Since then, IH shares have increased by 43.8% and is now trading at $2.43.

How were iHuman's earnings last quarter?

iHuman Inc. Sponsored ADR (NYSE:IH) released its quarterly earnings results on Thursday, June, 26th. The company reported $0.07 earnings per share (EPS) for the quarter. The company earned $29 million during the quarter. iHuman had a trailing twelve-month return on equity of 11.01% and a net margin of 11.44%.

When did iHuman IPO?

iHuman (IH) raised $84 million in an initial public offering on Friday, October 9th 2020. The company issued 7,000,000 shares at $11.00-$13.00 per share. Credit Suisse and Citigroup acted as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers.

How do I buy shares of iHuman?

Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iHuman own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iHuman investors own include Chevron (CVX), Baidu (BIDU), Tencent Music Entertainment Group (TME), Alibaba Group (BABA), Exxon Mobil (XOM), Abbott Laboratories (ABT) and JD.com (JD).

Company Calendar

• Record date for 5/15 Dividend: 4/17/2025
• Ex-Dividend for 5/15 Dividend: 4/17/2025
• Dividend Payable: 5/15/2025
• Last Earnings: 6/26/2025
• Today: 7/08/2025
• Next Earnings (Estimated): 9/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: SCHOOLS
• Sub-Industry: Personal Services
• Current Symbol: NYSE:IH
• CIK: 1814423
• Web: www.ihuman.com
• Phone: 86-10-5780-6636
• Fax: N/A
• Employees: 1,120
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.27
• Trailing P/E Ratio: 9.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $13.51 million
• Net Margins: 11.44%
• Pretax Margin: 11.99%
• Return on Equity: 11.01%
• Return on Assets: 7.33%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.98
• Quick Ratio: 2.93

Sales & Book Value

• Annual Sales: $126.34 million
• Price / Sales: 1.00
• Cash Flow: $0.29 per share
• Price / Cash Flow: 8.46
• Book Value: $2.53 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 52,020,000
• Free Float: 18,934,000
• Market Cap: $126.41 million
• Optionable: Not Optionable
• Beta: 0.38